| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Indaptus Therapeutics, Inc.
13D/A
INDP · 45339J105
|
12.7% |
12/30/2025
Event 12/22/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.